In the pharmaceutical and partly also in the fine chemicals industry many chemical conversions require stoichiometric amounts of reagents, and thus generate large amounts of waste [1, 2]. This is in contrast to the production of bulk chemicals which mostly relies on catalysis. This difference can be explained by the higher complexity of pharmaceuticals and fine chemicals which makes catalysis more demanding and process development more expensive. According
CITATION STYLE
Bonrath, W., Medlock, J., Schutz, J., Wustenberg, B., & Netscher, T. (2012). Hydrogenation in the Vitamins and Fine Chemicals Industry – An Overview. In Hydrogenation. InTech. https://doi.org/10.5772/48751
Mendeley helps you to discover research relevant for your work.